The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group

被引:92
作者
Forouhi, NG
Balkau, B
Borch-Johnsen, K
Dekker, J
Glumer, C
Qiao, Q
Spijkerman, A
Stolk, R
Tabac, A
Wareham, NJ
机构
[1] MRC, Elsie Widdowson Labs, Epidemiol Unit, Cambridge CB1 9NL, England
[2] INSERM, U258, IFR69, Villejuif, France
[3] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[4] Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands
[5] Univ Helsinki, Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland
[6] Univ Groningen, Univ Med Ctr, Dept Epidemiol & Bioinformat, Groningen, Netherlands
[7] Natl Ctr Diabet Care, Diabet Unit, Budapest, Hungary
基金
英国医学研究理事会;
关键词
D O I
10.1007/s00125-006-0189-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The category of IFG was introduced in the late 1990s to denote a state of non-diabetic hyperglycaemia defined by a fasting plasma glucose (FPG) concentration between 6.1 and 6.9 mmol/l. In 2003 the American Diabetes Association recommended that this diagnostic threshold be lowered to 5.6 mmol/l. The justification for lowering the threshold has been questioned. This simple change in cut-off value creates a pandemic of IFG, with a two- to five-fold increase in the prevalence of IFG across the world. Such a change in threshold has far-reaching public health implications. The European Diabetes Epidemiology Group (EDEG) has reviewed the evidence for this lower cut-off point for the definition of IFG and concludes that the previous definition should not be altered. EDEG further recommends that the value of all categorical definitions of non-diabetic hyperglycaemia should be reconsidered.
引用
收藏
页码:822 / 827
页数:6
相关论文
共 33 条
[1]   Comment to:: !Borch-Johnsen K, !Colagiuri S, !Balkau B et al (2004) Creating a pandemic of prediabetes:: the proposed new diagnostic criteria for impaired fasting glycaemia.: Diabetologia 47:1396-1402 [J].
Balkau, B ;
Hillier, T ;
Vierron, E ;
D'Hour, A ;
Lépinay, P ;
Royer, B ;
Born, C .
DIABETOLOGIA, 2005, 48 (04) :801-802
[2]   Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors - Results from the Baltimore Longitudinal Study on Aging [J].
Blake, DR ;
Meigs, JB ;
Muller, DC ;
Najjar, SS ;
Andres, R ;
Nathan, DM .
DIABETES, 2004, 53 (08) :2095-2100
[3]   Creating a pandemic of prediabetes:: the proposed new diagnostic criteria for impaired fasting glycaemia [J].
Borch-Johnsen, K ;
Colagiuri, S ;
Balkau, B ;
Glümer, C ;
Carstensen, B ;
Ramachandran, A ;
Dong, Y ;
Gao, W .
DIABETOLOGIA, 2004, 47 (08) :1396-1402
[4]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[5]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[6]   Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up [J].
Cicero, AFG ;
Dormi, A ;
Nascetti, S ;
Panourgia, MP ;
Grandi, E ;
D'Addato, S ;
Gaddi, A .
DIABETIC MEDICINE, 2005, 22 (09) :1263-1266
[7]   Lowering the criterion for impaired fasting glucose will not provide clinical benefit [J].
Davidson, MB ;
Landsman, PB ;
Alexander, CM .
DIABETES CARE, 2003, 26 (12) :3329-3330
[8]   Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[9]   Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:: the Hoorn Study [J].
de Vegt, F ;
Dekker, JM ;
Ruhé, HG ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
DIABETOLOGIA, 1999, 42 (08) :926-931
[10]   The fasting hyperglycaemia study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose [J].
Dyson, PA ;
Hammersley, MS ;
Morris, RJ ;
Holman, RR ;
Turner, RC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (12) :50-55